Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2003 October;44(5) > The Journal of Cardiovascular Surgery 2003 October;44(5):661-5

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

ORIGINAL ARTICLES  THORACIC SECTION 

The Journal of Cardiovascular Surgery 2003 October;44(5):661-5

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers

Nonami Y. 1, Ohtuki Y. 2, Sasaguri S. 1

1 Department of Surgery II, Kochi Medical School, Kochi, Japan 2 Department of Pathology II, Kochi Medical School, Kochi, Japan


Full text temporarily not available online. Contact us


Aim. ­When mul­tiple syn­chro­nous or met­a­chro­nous ­lung ­cancer ­lesions are iden­ti­fied, dis­crim­i­na­tion of mul­ti­cen­tric ­lung can­cers ­from intra­pul­mo­nary metas­tases by clin­ical find­ings is ­often dif­fi­cult. ­When ­tissue ­types ­have the ­same path­o­log­ical fea­tures, ­such as com­bi­na­tions of squa­mous ­cell car­ci­noma (SCC), aden­o­car­cinoma (AD) or bron­chiolo-­alveolar ­cell car­ci­noma (BAC), it is espe­cially dif­fi­cult to dis­tin­guish a ­2nd pri­mary ­lung ­cancer ­from a met­a­static ­lesion. A new ­strategy for accu­rate diag­nosis of mul­tiple syn­chro­nous or met­a­chro­nous ­lung ­cancer is ­needed ­because of the dif­fi­culty of his­to­log­ical dis­crim­i­na­tion.
­Methods. Of 363 ­patients ­with pri­mary ­lung ­cancer for ­which sur­geries ­were con­ducted at our hos­pital, 7 ­cases ­were diag­nosed as syn­chro­nous mul­tiple ­lung ­cancer (BAC-BAC in 4 ­cases and SCC-BAC in 3 ­cases) and 8 ­cases (BAC-BAC in 2 ­cases, AD-BAC in 1 ­case, AD-AD in 1 ­case, SCC-AD in 1 ­case and SCC-SCC in 3 ­cases) ­were diag­nosed as met­a­chro­nous mul­tiple ­lung ­cancer ­according to the clin­ical diag­nostic cri­teria. ­This ­study ­focused on 8 ­cases ­with the com­bi­na­tions AD-AD, AD-BAC, or BAC-BAC. For immu­no­his­to­chem­ical ­staining, we ­used the anti­bodies to 6 anti­gens as fol­lows: CK-19, p53, CEA, Hup-1, PE-10, and Ki-67.
­Results. Of 4 ­cases diag­nosed as syn­chro­nous ­lung ­cancer ­according to the clin­ical diag­nostic cri­teria, dif­fering immu­no­his­to­chem­ical ­stained ­images of the ­lesions ­were ­observed in 3 ­cases, ­while in the 4th ­case ­almost iden­tical immu­no­his­to­chem­ical ­stained ­images ­were ­obtained, ­which indi­cated the 2 ­lesions ­were the pri­mary and met­a­static ­focuses. Of 4 ­cases diag­nosed as met­a­chro­nous ­lung ­cancer ­according to the clin­ical diag­nostic cri­teria, ­almost iden­tical ­stained ­images ­were ­seen in 3 ­cases, ­which indi­cated the 2 ­lesions ­were the pri­mary and met­a­static ­focuses.
Con­clu­sion. In gen­eral, ­Type A and ­Type B in ­Noguchi’s BAC clas­sifi­ca­tion, ­tended to be mul­tiple syn­chro­nous or met­a­chro­nous ­lung ­cancer ­lesions, ­while AD and ­Type C in ­Noguchi’s BAC clas­sifi­ca­tion ­tended to be the met­a­static ­focus. For the ­focuses ­with ­tissue ­type of BAC-BAC, the ­staining ­using CK-19, PE-10, and Ki-67 was ­useful in dis­tin­guishing mul­tiple pri­mary ­lung ­cancer ­from pul­mo­nary metas­tasis in ­cases ­with a com­bi­na­tion of AD and BAC.

top of page